News from rewind therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

01 Aug, 2019, 08:05 BST Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates for Myelin-related Neurological Diseases

Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for myelin-related...


06 Feb, 2019, 07:00 GMT Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing Further Expertise in Myelin and Multiple Sclerosis Research

Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class remyelinating therapies for myelin-related...


10 Oct, 2018, 08:00 BST Rewind Therapeutics Builds Scientific Advisory Board to Accelerate Its Development of New Therapies for Myelin-Related Diseases

Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class therapies for myelin-related diseases, today...


03 Oct, 2018, 08:00 BST Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer

Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class therapies for myelin-related diseases,...